Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
124.37
+1.87 (1.53%)
At close: Oct 20, 2026, 4:00 PM EDT
125.00
+0.63 (0.51%)
After-hours: Oct 20, 2026, 7:51 PM EDT
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $115 → $130 | Buy | Reiterates | $115 → $130 | +4.53% | Oct 15, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $105 → $130 | Buy | Reiterates | $105 → $130 | +4.53% | Oct 13, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $70 → $78 | Hold | Reiterates | $70 → $78 | -37.28% | Oct 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $110 | Buy | Maintains | $110 | -11.55% | Oct 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 → $105 | Buy | Reiterates | $93 → $105 | -15.57% | Aug 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | -25.22% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $75 → $95 | Hold | Reiterates | $75 → $95 | -23.62% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $57 | Sell | Maintains | $57 | -54.17% | Jun 15, 2026 |